Close

Form 13F-HR TANG CAPITAL MANAGEMENT For: Mar 31

May 15, 2020 4:01 PM EDT

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

Report for the Calendar Year or Quarter Ended: 03-31-2020
Check here if Amendment   Amendment Number:
This Amendment (Check only one.):   is a restatement.
  adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: TANG CAPITAL MANAGEMENT LLC
Address: 4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO , CA92121
Form 13F File Number: 028-14822

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name: Kevin Tang
Title: Manager
Phone: 858-200-3830
Signature, Place, and Date of Signing:
/s/ Kevin Tang San Diego , CA 05-15-2020
[Signature] [City, State] [Date]
Report Type (Check only one.):
X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
  13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
  13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 1
Form 13F Information Table Entry Total: 25
Form 13F Information Table Value Total: 712,166
(thousands)
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
Form 13F File Number Name
028-14818 TANG KEVIN C

List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]
No. Form 13F File Number Name
1 028-14818 TANG KEVIN C

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ANAPTYSBIO INC COM 032724106 32,369 2,290,827 SH OTR 1 0 2,290,827 0
AVROBIO INC COM 05455M100 15,560 1,000,000 SH OTR 1 0 1,000,000 0
BIO RAD LABS INC CL A 090572207 28,045 80,000 SH OTR 1 0 80,000 0
CHIMERIX INC COM 16934W106 621 431,273 SH OTR 1 0 431,273 0
COHERUS BIOSCIENCES INC COM 19249H103 5,677 350,000 SH OTR 1 0 350,000 0
CYTOMX THERAPEUTICS INC COM 23284F105 2,301 300,000 SH OTR 1 0 300,000 0
EAGLE PHARMACEUTICALS INC COM 269796108 11,758 255,616 SH OTR 1 0 255,616 0
ENANTA PHARMACEUTICALS INC COM 29251M106 693 13,483 SH OTR 1 0 13,483 0
EVOLUS INC COM 30052C107 13,674 3,295,000 SH OTR 1 0 3,295,000 0
G1 THERAPEUTICS INC COM 3621LQ109 1,873 170,000 SH OTR 1 0 170,000 0
HERON THERAPEUTICS INC COM 427746102 34,010 2,896,904 SH OTR 1 0 2,896,904 0
INTRA CELLULAR THERAPIES INC COM 46116X101 637 41,444 SH OTR 1 0 41,444 0
LA JOLLA PHARMACEUTICAL CO COM 503459604 33,937 8,080,345 SH OTR 1 0 8,080,345 0
LIFESCI ACQUISITION CORP UNIT 03/31/2025 53228P208 4,999 500,000 SH OTR 1 0 500,000 0
NUCANA PLC SPONSORED ADR 67022C106 583 100,000 SH OTR 1 0 100,000 0
ODONATE THERAPEUTICS INC COM 676079106 388,618 14,075,269 SH OTR 1 0 14,075,269 0
PROTHENA CORP PLC SHS G72800108 4,535 423,823 SH OTR 1 0 423,823 0
PUMA BIOTECHNOLOGY INC COM 74587V107 6,752 800,000 SH OTR 1 0 800,000 0
RADIUS HEALTH INC COM NEW 750469207 3,900 300,000 SH OTR 1 0 300,000 0
RELMADA THERAPEUTICS INC COM 75955J402 44,343 1,300,000 SH OTR 1 0 1,300,000 0
ROCKET PHARMACEUTICALS INC COM 77313F106 41,369 2,965,485 SH OTR 1 0 2,965,485 0
SANGAMO THERAPEUTICS INC COM 800677106 12,950 2,032,980 SH OTR 1 0 2,032,980 0
UNITED PARCEL SERVICE INC CL B 911312106 93 1,000 SH OTR 1 0 1,000 0
UNITED THERAPEUTICS CORP DEL COM 91307C102 19,763 208,415 SH OTR 1 0 208,415 0
VANDA PHARMACEUTICALS INC COM 921659108 3,106 299,800 SH OTR 1 0 299,800 0


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

Tang Capital